These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 26872501)

  • 41. Comparing three forms of early intervention for youth with borderline personality disorder (the MOBY study): study protocol for a randomised controlled trial.
    Chanen A; Jackson H; Cotton SM; Gleeson J; Davey CG; Betts J; Reid S; Thompson K; McCutcheon L
    Trials; 2015 Oct; 16():476. PubMed ID: 26489661
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Neuropsychological rehabilitation in patients with borderline personality disorder: a case series].
    Arza R; Díaz-Marsá M; López-Micó C; de Pablo NF; López-Ibor JJ; Carrasco JL
    Actas Esp Psiquiatr; 2009; 37(4):236-9. PubMed ID: 19927237
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Theory of mind and its relationship with executive functions and emotion recognition in borderline personality disorder.
    Baez S; Marengo J; Perez A; Huepe D; Font FG; Rial V; Gonzalez-Gadea ML; Manes F; Ibanez A
    J Neuropsychol; 2015 Sep; 9(2):203-18. PubMed ID: 24766847
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neuropsychological findings in recent onset schizophrenia and borderline personality disorder: a comparison study.
    Palomares N; García-Andrade R; Arza R; Portella MJ; Díaz-Marsá M; López-Micó C; Carrasco JL
    Actas Esp Psiquiatr; 2019 Jan; 47(1):7-15. PubMed ID: 30724326
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy of cognitive rehabilitation using computer software with individuals living with schizophrenia: A randomized controlled trial in Japan.
    Iwata K; Matsuda Y; Sato S; Furukawa S; Watanabe Y; Hatsuse N; Ikebuchi E
    Psychiatr Rehabil J; 2017 Mar; 40(1):4-11. PubMed ID: 28182471
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relationships between childhood maltreatment, parenting style, and borderline personality disorder criteria.
    Hernandez A; Arntz A; Gaviria AM; Labad A; Gutiérrez-Zotes JA
    J Pers Disord; 2012 Oct; 26(5):727-36. PubMed ID: 23013341
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Selective deficit in executive functioning among patients with borderline personality disorder.
    Haaland VØ; Esperaas L; Landrø NI
    Psychol Med; 2009 Oct; 39(10):1733-43. PubMed ID: 19243646
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy of cognitive rehabilitation on psychosocial functioning in Borderline Personality Disorder: a randomized controlled trial.
    Pascual JC; Palomares N; Ibáñez Á; Portella MJ; Arza R; Reyes R; Feliu-Soler A; Díaz-Marsá M; Saiz-Ruiz J; Soler J; Carrasco JL
    BMC Psychiatry; 2015 Oct; 15():255. PubMed ID: 26487284
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An investigation of organic factors in the neuropsychological functioning of patients with borderline personality disorder.
    Travers C; King R
    J Pers Disord; 2005 Feb; 19(1):1-18. PubMed ID: 15899717
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impulsivity and aggressiveness in bipolar disorder with co-morbid borderline personality disorder.
    Carpiniello B; Lai L; Pirarba S; Sardu C; Pinna F
    Psychiatry Res; 2011 Jun; 188(1):40-4. PubMed ID: 21131058
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The neuropsychological correlates of borderline personality disorder and suicidal behaviour.
    LeGris J; van Reekum R
    Can J Psychiatry; 2006 Mar; 51(3):131-42. PubMed ID: 16618004
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effectiveness of cognitive remediation therapy in patients with a severe or enduring eating disorder: a randomized controlled trial.
    Dingemans AE; Danner UN; Donker JM; Aardoom JJ; van Meer F; Tobias K; van Elburg AA; van Furth EF
    Psychother Psychosom; 2014; 83(1):29-36. PubMed ID: 24281361
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Computer-assisted cognitive remediation for schizophrenia: a randomized single-blind pilot study.
    Rass O; Forsyth JK; Bolbecker AR; Hetrick WP; Breier A; Lysaker PH; O'Donnell BF
    Schizophr Res; 2012 Aug; 139(1-3):92-8. PubMed ID: 22682988
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Do patients with bipolar disorder and subsyndromal symptoms benefit from functional remediation? A 12-month follow-up study.
    Sanchez-Moreno J; Bonnín C; González-Pinto A; Amann BL; Solé B; Balanzá-Martínez V; Arango C; Jimenez E; Tabarés-Seisdedos R; Garcia-Portilla MP; Ibáñez A; Crespo JM; Ayuso-Mateos JL; Vieta E; Martinez-Aran A; Torrent C;
    Eur Neuropsychopharmacol; 2017 Apr; 27(4):350-359. PubMed ID: 28126401
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Computer-aided neurocognitive remediation as an enhancing strategy for schizophrenia rehabilitation.
    Cavallaro R; Anselmetti S; Poletti S; Bechi M; Ermoli E; Cocchi F; Stratta P; Vita A; Rossi A; Smeraldi E
    Psychiatry Res; 2009 Oct; 169(3):191-6. PubMed ID: 19740550
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The association between attentional and executive controls in the expression of borderline personality disorder features: a preliminary study.
    Fertuck EA; Lenzenweger MF; Clarkin JF
    Psychopathology; 2005; 38(2):75-81. PubMed ID: 15802945
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Does practice make perfect? Results from a Chinese feasibility study of cognitive remediation in schizophrenia.
    Byrne LK; Peng D; McCabe M; Mellor D; Zhang J; Zhang T; Huang J; Xu Y
    Neuropsychol Rehabil; 2013; 23(4):580-96. PubMed ID: 23697371
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cognitive remediation therapy: is it a feasible and acceptable psychological treatment for borderline personality disorder?
    Dinu B; Dark F
    Australas Psychiatry; 2023 Jun; 31(3):312-314. PubMed ID: 36341496
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A dose comparison of olanzapine for the treatment of borderline personality disorder: a 12-week randomized, double-blind, placebo-controlled study.
    Zanarini MC; Schulz SC; Detke HC; Tanaka Y; Zhao F; Lin D; Deberdt W; Kryzhanovskaya L; Corya S
    J Clin Psychiatry; 2011 Oct; 72(10):1353-62. PubMed ID: 21535995
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The neuropsychology of borderline personality disorder: relationship with clinical dimensions and comparison with other personality disorders.
    Seres I; Unoka Z; Bódi N; Aspán N; Kéri S
    J Pers Disord; 2009 Dec; 23(6):555-62. PubMed ID: 20001174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.